These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the principle of focusing on ACKR3 as a unique way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Issues. Notice: Outcomes could https://ericw060kqs4.wikisona.com/user